CD70 and neoplasm: Conversely, aberrant expression of CD70 has been observed in several types of malignancies, such as RCC and nasopharyngeal carcinoma, leading to lymphocyte apoptosis, T cell exhaustion and immune evasion, which promote tumor progression [216, 218, 219].